RCM
ARNA

Reynolds Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Reynolds Capital Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,310
Closed -$101K – 473
2013
Q2 		$101K Buy
+1,310
New +$107K 0.07% 353

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Reynolds Capital Management's ARNA Position: Q3 2013 in Review

Reynolds Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2013, closing a stake of 1,310 shares — an estimated $101K sold.

Reynolds Capital Management first reported a position in ARNA in Q2 2013 and held it in 1 quarter. The position peaked at $101K in Q2 2013. 140 funds tracked by Wall St. Rank hold ARNA as of Q3 2013.

  • Reynolds Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • Reynolds Capital Management sold 1,310 Arena Pharmaceuticals Inc shares in Q3 2013, an estimated $101K.
  • Reynolds Capital Management first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • Reynolds Capital Management's Arena Pharmaceuticals Inc position peaked at $101K in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2013.

Based on Reynolds Capital Management's 13F filing for Q3 2013, filed 6 Nov 2013.